Waddell & Reed Financial’s Aratana Therapeutics, Inc. PETX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-80,000
| Closed | -$506K | – | 625 |
|
|
2016
Q2 | $506K | Sell |
80,000
-121,500
| -60% | -$768K | ﹤0.01% | 575 |
|
|
2016
Q1 | $1.11M | Sell |
201,500
-48,500
| -19% | -$268K | ﹤0.01% | 580 |
|
|
2015
Q4 | $1.4M | Sell |
250,000
-918,500
| -79% | -$5.13M | ﹤0.01% | 605 |
|
|
2015
Q3 | $9.89M | Buy |
1,168,500
+1,003,500
| +608% | +$8.49M | 0.02% | 405 |
|
|
2015
Q2 | $2.5M | Sell |
165,000
-40,000
| -20% | -$605K | ﹤0.01% | 536 |
|
|
2015
Q1 | $3.28M | Buy |
205,000
+5,000
| +3% | +$80K | ﹤0.01% | 525 |
|
|
2014
Q4 | $3.56M | Sell |
200,000
-200,600
| -50% | -$3.57M | ﹤0.01% | 509 |
|
|
2014
Q3 | $4.02M | Sell |
400,600
-10,000
| -2% | -$100K | 0.01% | 506 |
|
|
2014
Q2 | $6.41M | Sell |
410,600
-45,600
| -10% | -$712K | 0.01% | 485 |
|
|
2014
Q1 | $8.47M | Buy |
+456,200
| New | +$8.47M | 0.01% | 455 |
|